About our project

The problem we solve: People spend billions on “wellness” powders, gummies, and stacks, yet 90% of the reviews guiding those purchases come from anonymous shoppers or paid influencers—not licensed clinicians. Patients often wonder about the efficacy of various trending supplements and clinicians' opinions often get muffled. No one can see real-world efficacy or safety signals, so money is wasted and patients risk unproven—or harmful—products. We need a single, trustworthy channel for true clinical feedback.

About our solution: SupDoc solves this blind spot by giving verified clinicians a fast, familiar way to rate supplements and surface the signal. Reviewers sign up with NPI or hospital e-mail, select a product, and leave a 1–5-star score plus quick evidence tags (efficacy, side-effects, FDA status, specialty use). Comments are time-stamped, peer-rated, and fully transparent. The front end shows consumers an easy “traffic-light” guide, while the backend aggregates de-identified ratings into paid dashboards for retailers, clinicians, and researchers. Early clinicians receive a free Pro year and cash honoraria for deeper reviews, seeding high-quality content before the network effect takes hold. SupDoc turns scattered expert anecdotes into a living database that helps shoppers buy safely, hospitals stock wisely, and scientists spot real-world trends months sooner.

Progress to date:

SupDoc, LLC is fully formed (EIN secured) and our web-app is ~50 % complete. The React + Tailwind front-end already supports clinician sign-up, NPI verification, and basic supplement search; ratings and evidence-tag components are in active development. We’ve assembled a waitlist of 20+ licensed clinicians—recruited through LinkedIn and specialty Slack channels—who have committed to beta-test in exchange for a complimentary Pro year. Funding from this campaign will finish the remaining feature set (review feed, analytics dashboard, honorarium payout flow) and take us from working prototype to public launch.

About Our Company

How We Help Patients

SupDoc puts clinicians’ real-world experience back into every supplement decision patients make. When a person googles “Should I take magnesium for sleep?” today, they sift through anonymous Amazon stars and influencer TikToks. Our platform replaces that noise with concise, peer-reviewed guidance:

• Clear safety flags – red badges surface reported side-effects and drug interactions before harm occurs.

• Evidence scores – patients instantly see whether claims are backed by randomized trials, observational data, or just marketing hype.

• Personalized search – filters by age, condition, pregnancy status, or comorbidities route people to products clinicians actually recommend for their profile.

Result: fewer wasted dollars on ineffective pills, earlier detection of risky trends (e.g., liver toxicity), and informed shared-decision conversations in clinic. By turning frontline insights into an open, living guide, SupDoc helps millions choose safer, evidence-aligned supplements—extending healthier lives one purchase at a time.

How We Help Physicians

SupDoc finally gives clinicians what’s been missing: a fast, structured, peer-only pulse on the booming supplement market—plus the data backbone to surface clinical signals hiding in plain sight. Instead of hunting PubMed or debunking influencer claims at the bedside, a provider can log in and instantly see:

• average 1-5-star rating from verified peers

• tagged clinical goals (sleep, anxiety, fertility) and real-world dose ranges

• red-flag side-effect frequency 

• links to any RCTs or FDA warning letters

Why that matters at the bedside
• Cuts “Dr Google” debate time—30 seconds on SupDoc can replace a 10-minute counselling digression.
• Builds trust: patients hear the same recommendation from multiple independent clinicians, not one opinion versus the internet.
• Improves safety: pharmacists flag supplement–drug interactions in one search; dietitians stratify brands by contaminant reports.

The aggregation advantage
Every rating feeds an anonymized data lake. Dashboards let clinicians slice by age, sex, comorbidity, and dose to surface patterns a single practice could never see—e.g., a magnesium glycinate brand linked to fewer GI complaints in post-bariatric patients, or an unexpected spike in liver enzymes with a “detox” blend. These crowd-sourced trends spark new research questions, quality-improvement projects, and even publishable studies, giving contributors first-mover insight into discoveries that improve care.

Why it matters for practice management
• Clinics and hospitals gain an evidence-weighted formulary for OTCs, reducing liability from stocking low-quality products.
• Population analytics highlight adverse-event clusters weeks before journal case reports appear.
• CME/CE credit potential: top reviewers earn hours while their insights push practice forward.

Workflow fit
SupDoc will surface inside the EHR via a FHIR-compatible pop-up (pilot Q4-2026). One click drops a concise supplement summary into the after-visit instructions—no extra log-ins.

Why providers contribute
We verify every professional through NPI / hospital e-mail, publish leaderboards, and pay an honorarium ($10-$25 per in-depth review) after the first free year. Early reviewers lock in “Founding Clinician” status, secure passive income for updates, and gain privileged access to the trend dashboards that their own data helped create.

In short, SupDoc lets busy clinicians give evidence-based supplement advice in seconds, reveal hidden population-level signals, and get paid for elevating the standard of care.

How We Help Hospitals

Hospitals are legally and ethically accountable for every product that reaches the bedside or their retail pharmacies, yet the OTC-supplement aisle is still a clinical “blind spot.” Pharmacy & Therapeutics (P&T) committees lack real-world performance data, infection-control teams have no early-warning system for contaminated lots, and clinicians waste precious minutes countering influencer myths during discharge teaching. SupDoc closes that gap with a hospital-grade signal layer built on verified clinician reviews.

• Evidence-weighted supplement formulary – Our NPI-verified star ratings, side-effect frequencies, and FDA-warning tags feed an enterprise dashboard that pharmacy leaders can filter by therapeutic goal, patient population, and price. Formularies update in near-real-time instead of waiting for annual literature reviews.

• Early adverse-event detection – Aggregated reviews surface clusters (e.g., elevated LFTs with Brand X “detox” blend) weeks before case reports or FDA notices, letting quality & safety teams pull stock, notify clinicians, and prevent harm.

• Discharge & patient-education efficiency – A FHIR-compatible plugin (pilot 2026) drops a concise, evidence-based supplement summary into the AVS with one click, trimming 5–10 minutes of bedside counseling and improving HCAHPS “Communication about Medications” scores.

• Cost & margin optimization – Supply-chain teams can benchmark brands by clinician-rated efficacy per dollar, negotiate better contracts, and eliminate ineffective SKUs. For systems with retail pharmacies, trustworthy “Hospital-Recommended” badges drive higher basket sizes without ethical conflicts.

• Research & reputation – De-identified trend data support investigator-initiated trials or QI projects. Early hospital partners receive co-authorship opportunities on white-papers (“Real-World Magnesium Use in Bariatric Patients”) and public recognition as Supplement Safety Collaborative charter members.

• Implementation – SupDoc requires no device procurement. Initial integration is secure SSO plus read-only EHR context; advanced modules (CDS hooks, formulary pushes) follow. HIPAA risk is minimal: no PHI is stored, only hashed clinician IDs.

How We Help Partners

Supplement & Wellness Brands
SupDoc gives quality-focused brands a transparent channel to earn clinician trust. By encouraging verified physicians, pharmacists, and dietitians to review their products, companies can highlight real-world efficacy data instead of influencer hype. In return, we offer brands a HIPAA-compliant dashboard that surfaces anonymized sentiment trends and side-effect flags—actionable feedback they’ve never had. Early partners receive discounted “claim-evidence” widgets they can embed on DTC pages once a product reaches ≥50 clinician reviews.

Retail & Pharmacy Chains
Large retailers (e.g., CVS, Walgreens, H-E-B) struggle to select safe, evidence-backed SKUs from 100 000+ supplement listings. SupDoc’s aggregated ratings and red-flag alerts help buyers rationalize shelf space, reduce recalls, and lower liability. Pilot partners get quarterly formulary-optimization reports and co-branding on our consumer-facing “Top-Rated by Clinicians” badge—driving both foot-traffic and trust.

Clinical Researchers & Academic Centers
Our continuous data stream of real-world outcomes creates an inexpensive hypothesis-generation engine. Universities and CROs can license de-identified datasets sliced by dose, demographic, and comorbidity to design faster RCTs or pharmacovigilance studies. In exchange, we’ll cross-promote calls for study participants and invite investigators to publish mini-analyses on SupDoc’s “Insights” blog, elevating their visibility.

Why partner early?
Founding partners lock in multi-year preferred pricing, shape our API & dashboard road-map, and receive monthly data-strategy calls with our team. Together, we shrink the supplement evidence gap, boost consumer safety, and unlock new revenue based on trust—not hype.

Innovation Details

Intellectual Property Summary

SupDoc’s concept, name, and code are protected by standard copyright and trademark rights as we develop, but there is no patentable invention or trade-secret algorithm being disclosed. We are openly sharing the idea to attract clinical reviewers and early customers, so there is nothing that needs provisional or issued patent coverage at this stage. Future proprietary features (e.g., analytics models) can be patented or kept confidential once built and validated.

Clinical Information

SupDoc is an information-sharing platform, not a therapeutic. Our “efficacy” comes from capturing real-world evidence already generated in practice: every review is authored by an NPI-verified clinician and tagged for indication, outcomes observed, and side-effects. By aggregating hundreds of such micro-data points we will produce dashboards similar to post-marketing surveillance literature (e.g., FAERS, Real-World Evidence studies in JAMA). Phase I: pilot cohort of 20+ physicians, pharmacists, and RDs who have committed to supply ≥5 structured supplement reviews each, giving us 100-plus clinician-authored data points to validate tagging, inter-rater reliability, and usability. Future phases will be submitted for IRB exemption as minimal-risk survey research so we can publish methodology and compare accuracy against consumer-only review sites.

Regulatory Status

SupDoc itself is a health-information marketplace, not a medical device or drug; therefore no FDA clearance is required. We do not diagnose, treat, or dispense products—only host clinician opinions and label them as such in compliance with Section 230 and FTC endorsement guidelines.

How we will use the funds raised

Every dollar moves SupDoc from a half-built prototype to a public launch focused on supplements.

• $22 k – Full-stack build-out (React, Node, AWS, secure NPI verification)
  Finish search, ratings, and analytics dashboard; add HIPAA-grade security.

• $8 k – Clinician honoraria & early-review program
  Stipends for our first 50 physicians, pharmacists, and dietitians to produce ≥500 structured supplement reviews in 90 days.

• $5 k – Evidence engine & AI summaries
  Integrate PubMed/ClinicalTrials.gov look-ups and generate plain-language evidence tags.

• $3 k – Compliance & legal
  Terms of use, FTC/endorsement review, LLC accounting, insurance.

• $2 k – Hosting, monitoring, and incident response runway (12 months)

Total: $40 k delivers the public MVP, a rich starter dataset, and a clear revenue hand-off (clinician Pro tier + B2B data licensing).

Thank You

Hi, I’m Jerald, an MD candidate and former toxicology researcher who’s tired of seeing people trust Reddit threads over real science. SupDoc lets verified clinicians review supplements so families and retailers finally see an evidence-based signal instead of marketing noise.

If you believe the people selling supplemental powders and gummies shouldn’t be louder than the doctors who treat the consequences, back this campaign. Your support finishes the build, pays early reviewers, and puts an honest, searchable guide in every supplement aisle.

Join us and help us make clinical expertise impossible to ignore.

Supporters

• 
  Linda Stotsky
  06/28/2025 - Followed the project.
• 
  Linda Stotsky
  06/28/2025 - Liked the project.

Comments

• 
  Linda Stotsky posted on 28th June, 2025

  This is a really useful app! So many of us take supplements and it would be excellent to have certified clinical reviews!

  Report as Spam

Updates

No updates found .